'''Enprofylline''' ('''3-propylxanthine''') is a [[xanthine]] derivative used in the treatment of [[asthma]], which acts as a [[bronchodilator]]. It acts primarily as a competitive nonselective [[phosphodiesterase inhibitor]] with relatively little activity as a nonselective [[adenosine receptor]] antagonist.<ref name="pmid6288396">{{cite journal |vauthors=Lunell E, Svedmyr N, Andersson KE, Persson CG |title=Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung disease |journal=European Journal of Clinical Pharmacology |volume=22 |issue=5 |pages=395–402 |year=1982 |pmid=6288396 |doi= 10.1007/bf00542541|url=}}</ref><ref name="pmid3325233">{{cite journal |author=Laursen LC |title=Anti asthmatic effects and pharmacokinetics of enprofylline--a new xanthine derivate |journal=Danish Medical Bulletin |volume=34 |issue=6 |pages=289–97 |date=December 1987 |pmid=3325233 |doi= |url=}}</ref>
